essence trial semaglutide In an interim analysis of a phase 3 involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full trial results and Research Summary EASL 2026 - Semaglutide Provides
Description
GLP-1s are FDA-approved and clinically proven medications
However, we used new users as a cohort to reduce the potential for unmeasured confounding
Um it was the average age, uh mean age of around 63 years, but it was stopped early because it was linked to one more breast cancer case per a thousand patients per year
Very kind and knowledgeable staff
In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) was resolved
